Breast cancer is a highly heterogeneous disease, and it can be classified into molecular subtypes based on the expression of key receptors: estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) [2,3,4]. This evidence concerns the gene ERBB2 and breast carcinoma.